+1 (704) 266-3234

Global And China Expression Competent Cells Market Size, Status And Forecast 2021-2027

Published on: Aug 2021 | From USD $2900 | Published By: QY RESEARCH | Number Of Pages: 128

The Protein Expression Competent Cell Pack lets you efficiently economically optimize expression by simultaneously testing multiple strains with your gene of interest. The pack includes BL21(DE3) competent cells for nontoxic proteins and BL21(DE3) pLysS competent cells for both toxic and nontoxic proteins.

Market Analysis and Insights: Global Expression Competent Cells Market
The global Expression Competent Cells market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Expression Competent Cells market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Expression Competent Cells market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Expression Competent Cells market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Expression Competent Cells market.

Global Expression Competent Cells Scope and Market Size
Expression Competent Cells market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Expression Competent Cells market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Chemically Competent Cells
Electrocompetent Cells

Segment by Application
Protein Expression
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Expression Competent Cells Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemically Competent Cells
1.2.3 Electrocompetent Cells
1.3 Market by Application
1.3.1 Global Expression Competent Cells Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Protein Expression
1.3.3 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Expression Competent Cells Market Perspective (2016-2027)
2.2 Expression Competent Cells Growth Trends by Regions
2.2.1 Expression Competent Cells Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Expression Competent Cells Historic Market Share by Regions (2016-2021)
2.2.3 Expression Competent Cells Forecasted Market Size by Regions (2022-2027)
2.3 Expression Competent Cells Industry Dynamic
2.3.1 Expression Competent Cells Market Trends
2.3.2 Expression Competent Cells Market Drivers
2.3.3 Expression Competent Cells Market Challenges
2.3.4 Expression Competent Cells Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Expression Competent Cells Players by Revenue
3.1.1 Global Top Expression Competent Cells Players by Revenue (2016-2021)
3.1.2 Global Expression Competent Cells Revenue Market Share by Players (2016-2021)
3.2 Global Expression Competent Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Expression Competent Cells Revenue
3.4 Global Expression Competent Cells Market Concentration Ratio
3.4.1 Global Expression Competent Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Expression Competent Cells Revenue in 2020
3.5 Expression Competent Cells Key Players Head office and Area Served
3.6 Key Players Expression Competent Cells Product Solution and Service
3.7 Date of Enter into Expression Competent Cells Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Expression Competent Cells Breakdown Data by Type
4.1 Global Expression Competent Cells Historic Market Size by Type (2016-2021)
4.2 Global Expression Competent Cells Forecasted Market Size by Type (2022-2027)

5 Expression Competent Cells Breakdown Data by Application
5.1 Global Expression Competent Cells Historic Market Size by Application (2016-2021)
5.2 Global Expression Competent Cells Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Expression Competent Cells Market Size (2016-2027)
6.2 North America Expression Competent Cells Market Size by Type
6.2.1 North America Expression Competent Cells Market Size by Type (2016-2021)
6.2.2 North America Expression Competent Cells Market Size by Type (2022-2027)
6.2.3 North America Expression Competent Cells Market Size by Type (2016-2027)
6.3 North America Expression Competent Cells Market Size by Application
6.3.1 North America Expression Competent Cells Market Size by Application (2016-2021)
6.3.2 North America Expression Competent Cells Market Size by Application (2022-2027)
6.3.3 North America Expression Competent Cells Market Size by Application (2016-2027)
6.4 North America Expression Competent Cells Market Size by Country
6.4.1 North America Expression Competent Cells Market Size by Country (2016-2021)
6.4.2 North America Expression Competent Cells Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Expression Competent Cells Market Size (2016-2027)
7.2 Europe Expression Competent Cells Market Size by Type
7.2.1 Europe Expression Competent Cells Market Size by Type (2016-2021)
7.2.2 Europe Expression Competent Cells Market Size by Type (2022-2027)
7.2.3 Europe Expression Competent Cells Market Size by Type (2016-2027)
7.3 Europe Expression Competent Cells Market Size by Application
7.3.1 Europe Expression Competent Cells Market Size by Application (2016-2021)
7.3.2 Europe Expression Competent Cells Market Size by Application (2022-2027)
7.3.3 Europe Expression Competent Cells Market Size by Application (2016-2027)
7.4 Europe Expression Competent Cells Market Size by Country
7.4.1 Europe Expression Competent Cells Market Size by Country (2016-2021)
7.4.2 Europe Expression Competent Cells Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Expression Competent Cells Market Size (2016-2027)
8.2 Asia-Pacific Expression Competent Cells Market Size by Type
8.2.1 Asia-Pacific Expression Competent Cells Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Expression Competent Cells Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Expression Competent Cells Market Size by Type (2016-2027)
8.3 Asia-Pacific Expression Competent Cells Market Size by Application
8.3.1 Asia-Pacific Expression Competent Cells Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Expression Competent Cells Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Expression Competent Cells Market Size by Application (2016-2027)
8.4 Asia-Pacific Expression Competent Cells Market Size by Region
8.4.1 Asia-Pacific Expression Competent Cells Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Expression Competent Cells Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Expression Competent Cells Market Size (2016-2027)
9.2 Latin America Expression Competent Cells Market Size by Type
9.2.1 Latin America Expression Competent Cells Market Size by Type (2016-2021)
9.2.2 Latin America Expression Competent Cells Market Size by Type (2022-2027)
9.2.3 Latin America Expression Competent Cells Market Size by Type (2016-2027)
9.3 Latin America Expression Competent Cells Market Size by Application
9.3.1 Latin America Expression Competent Cells Market Size by Application (2016-2021)
9.3.2 Latin America Expression Competent Cells Market Size by Application (2022-2027)
9.3.3 Latin America Expression Competent Cells Market Size by Application (2016-2027)
9.4 Latin America Expression Competent Cells Market Size by Country
9.4.1 Latin America Expression Competent Cells Market Size by Country (2016-2021)
9.4.2 Latin America Expression Competent Cells Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Expression Competent Cells Market Size (2016-2027)
10.2 Middle East & Africa Expression Competent Cells Market Size by Type
10.2.1 Middle East & Africa Expression Competent Cells Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Expression Competent Cells Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Expression Competent Cells Market Size by Type (2016-2027)
10.3 Middle East & Africa Expression Competent Cells Market Size by Application
10.3.1 Middle East & Africa Expression Competent Cells Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Expression Competent Cells Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Expression Competent Cells Market Size by Application (2016-2027)
10.4 Middle East & Africa Expression Competent Cells Market Size by Country
10.4.1 Middle East & Africa Expression Competent Cells Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Expression Competent Cells Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Company Details
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA Expression Competent Cells Introduction
11.1.4 Merck KGaA Revenue in Expression Competent Cells Business (2016-2021)
11.1.5 Merck KGaA Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Expression Competent Cells Introduction
11.2.4 Thermo Fisher Scientific Revenue in Expression Competent Cells Business (2016-2021)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Details
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Expression Competent Cells Introduction
11.3.4 Agilent Technologies Revenue in Expression Competent Cells Business (2016-2021)
11.3.5 Agilent Technologies Recent Development
11.4 Takara Bio
11.4.1 Takara Bio Company Details
11.4.2 Takara Bio Business Overview
11.4.3 Takara Bio Expression Competent Cells Introduction
11.4.4 Takara Bio Revenue in Expression Competent Cells Business (2016-2021)
11.4.5 Takara Bio Recent Development
11.5 Promega Corporation
11.5.1 Promega Corporation Company Details
11.5.2 Promega Corporation Business Overview
11.5.3 Promega Corporation Expression Competent Cells Introduction
11.5.4 Promega Corporation Revenue in Expression Competent Cells Business (2016-2021)
11.5.5 Promega Corporation Recent Development
11.6 Beijing TransGen Biotech
11.6.1 Beijing TransGen Biotech Company Details
11.6.2 Beijing TransGen Biotech Business Overview
11.6.3 Beijing TransGen Biotech Expression Competent Cells Introduction
11.6.4 Beijing TransGen Biotech Revenue in Expression Competent Cells Business (2016-2021)
11.6.5 Beijing TransGen Biotech Recent Development
11.7 GeneScript Corporation
11.7.1 GeneScript Corporation Company Details
11.7.2 GeneScript Corporation Business Overview
11.7.3 GeneScript Corporation Expression Competent Cells Introduction
11.7.4 GeneScript Corporation Revenue in Expression Competent Cells Business (2016-2021)
11.7.5 GeneScript Corporation Recent Development
11.8 Yeastern Biotech
11.8.1 Yeastern Biotech Company Details
11.8.2 Yeastern Biotech Business Overview
11.8.3 Yeastern Biotech Expression Competent Cells Introduction
11.8.4 Yeastern Biotech Revenue in Expression Competent Cells Business (2016-2021)
11.8.5 Yeastern Biotech Recent Development
11.9 New England Biolabs
11.9.1 New England Biolabs Company Details
11.9.2 New England Biolabs Business Overview
11.9.3 New England Biolabs Expression Competent Cells Introduction
11.9.4 New England Biolabs Revenue in Expression Competent Cells Business (2016-2021)
11.9.5 New England Biolabs Recent Development
11.10 QIAGEN N.V.
11.10.1 QIAGEN N.V. Company Details
11.10.2 QIAGEN N.V. Business Overview
11.10.3 QIAGEN N.V. Expression Competent Cells Introduction
11.10.4 QIAGEN N.V. Revenue in Expression Competent Cells Business (2016-2021)
11.10.5 QIAGEN N.V. Recent Development
11.11 OriGene Technologies
11.11.1 OriGene Technologies Company Details
11.11.2 OriGene Technologies Business Overview
11.11.3 OriGene Technologies Expression Competent Cells Introduction
11.11.4 OriGene Technologies Revenue in Expression Competent Cells Business (2016-2021)
11.11.5 OriGene Technologies Recent Development
11.12 Lucigen
11.12.1 Lucigen Company Details
11.12.2 Lucigen Business Overview
11.12.3 Lucigen Expression Competent Cells Introduction
11.12.4 Lucigen Revenue in Expression Competent Cells Business (2016-2021)
11.12.5 Lucigen Recent Development
11.13 Zymo Research
11.13.1 Zymo Research Company Details
11.13.2 Zymo Research Business Overview
11.13.3 Zymo Research Expression Competent Cells Introduction
11.13.4 Zymo Research Revenue in Expression Competent Cells Business (2016-2021)
11.13.5 Zymo Research Recent Development
11.14 Bio-Rad Laboratories
11.14.1 Bio-Rad Laboratories Company Details
11.14.2 Bio-Rad Laboratories Business Overview
11.14.3 Bio-Rad Laboratories Expression Competent Cells Introduction
11.14.4 Bio-Rad Laboratories Revenue in Expression Competent Cells Business (2016-2021)
11.14.5 Bio-Rad Laboratories Recent Development
11.15 Bioline
11.15.1 Bioline Company Details
11.15.2 Bioline Business Overview
11.15.3 Bioline Expression Competent Cells Introduction
11.15.4 Bioline Revenue in Expression Competent Cells Business (2016-2021)
11.15.5 Bioline Recent Development
11.16 Delphi Genetics
11.16.1 Delphi Genetics Company Details
11.16.2 Delphi Genetics Business Overview
11.16.3 Delphi Genetics Expression Competent Cells Introduction
11.16.4 Delphi Genetics Revenue in Expression Competent Cells Business (2016-2021)
11.16.5 Delphi Genetics Recent Development
11.17 IBA GmBH
11.17.1 IBA GmBH Company Details
11.17.2 IBA GmBH Business Overview
11.17.3 IBA GmBH Expression Competent Cells Introduction
11.17.4 IBA GmBH Revenue in Expression Competent Cells Business (2016-2021)
11.17.5 IBA GmBH Recent Development
11.18 Cell Applications
11.18.1 Cell Applications Company Details
11.18.2 Cell Applications Business Overview
11.18.3 Cell Applications Expression Competent Cells Introduction
11.18.4 Cell Applications Revenue in Expression Competent Cells Business (2016-2021)
11.18.5 Cell Applications Recent Development
11.18 BioDynamics Laboratory
.1 BioDynamics Laboratory Company Details
.2 BioDynamics Laboratory Business Overview
.3 BioDynamics Laboratory Expression Competent Cells Introduction
.4 BioDynamics Laboratory Revenue in Expression Competent Cells Business (2016-2021)
.5 BioDynamics Laboratory Recent Development
11.20 Scarab Genomics
11.20.1 Scarab Genomics Company Details
11.20.2 Scarab Genomics Business Overview
11.20.3 Scarab Genomics Expression Competent Cells Introduction
11.20.4 Scarab Genomics Revenue in Expression Competent Cells Business (2016-2021)
11.20.5 Scarab Genomics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Expression Competent Cells Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemically Competent Cells
Table 3. Key Players of Electrocompetent Cells
Table 4. Global Expression Competent Cells Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Expression Competent Cells Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Expression Competent Cells Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Expression Competent Cells Market Share by Regions (2016-2021)
Table 8. Global Expression Competent Cells Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Expression Competent Cells Market Share by Regions (2022-2027)
Table 10. Expression Competent Cells Market Trends
Table 11. Expression Competent Cells Market Drivers
Table 12. Expression Competent Cells Market Challenges
Table 13. Expression Competent Cells Market Restraints
Table 14. Global Expression Competent Cells Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Expression Competent Cells Market Share by Players (2016-2021)
Table 16. Global Top Expression Competent Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Expression Competent Cells as of 2020)
Table 17. Ranking of Global Top Expression Competent Cells Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Expression Competent Cells Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Expression Competent Cells Product Solution and Service
Table 21. Date of Enter into Expression Competent Cells Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Expression Competent Cells Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Expression Competent Cells Revenue Market Share by Type (2016-2021)
Table 25. Global Expression Competent Cells Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Expression Competent Cells Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Expression Competent Cells Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Expression Competent Cells Revenue Market Share by Application (2016-2021)
Table 29. Global Expression Competent Cells Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Expression Competent Cells Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Expression Competent Cells Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Expression Competent Cells Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Expression Competent Cells Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Expression Competent Cells Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Expression Competent Cells Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Expression Competent Cells Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Expression Competent Cells Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Expression Competent Cells Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Expression Competent Cells Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Expression Competent Cells Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Expression Competent Cells Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Expression Competent Cells Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Expression Competent Cells Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Expression Competent Cells Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Expression Competent Cells Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Expression Competent Cells Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Expression Competent Cells Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Expression Competent Cells Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Expression Competent Cells Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Expression Competent Cells Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Expression Competent Cells Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Expression Competent Cells Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Expression Competent Cells Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Expression Competent Cells Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Expression Competent Cells Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Expression Competent Cells Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Expression Competent Cells Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Expression Competent Cells Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Expression Competent Cells Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Expression Competent Cells Market Size by Country (2022-2027) & (US$ Million)
Table 61. Merck KGaA Company Details
Table 62. Merck KGaA Business Overview
Table 63. Merck KGaA Expression Competent Cells Product
Table 64. Merck KGaA Revenue in Expression Competent Cells Business (2016-2021) & (US$ Million)
Table 65. Merck KGaA Recent Development
Table 66. Thermo Fisher Scientific Company Details
Table 67. Thermo Fisher Scientific Business Overview
Table 68. Thermo Fisher Scientific Expression Competent Cells Product
Table 69. Thermo Fisher Scientific Revenue in Expression Competent Cells Business (2016-2021) & (US$ Million)
Table 70. Thermo Fisher Scientific Recent Development
Table 71. Agilent Technologies Company Details
Table 72. Agilent Technologies Business Overview
Table 73. Agilent Technologies Expression Competent Cells Product
Table 74. Agilent Technologies Revenue in Expression Competent Cells Business (2016-2021) & (US$ Million)
Table 75. Agilent Technologies Recent Development
Table 76. Takara Bio Company Details
Table 77. Takara Bio Business Overview
Table 78. Takara Bio Expression Competent Cells Product
Table 79. Takara Bio Revenue in Expression Competent Cells Business (2016-2021) & (US$ Million)
Table 80. Takara Bio Recent Development
Table 81. Promega Corporation Company Details
Table 82. Promega Corporation Business Overview
Table 83. Promega Corporation Expression Competent Cells Product
Table 84. Promega Corporation Revenue in Expression Competent Cells Business (2016-2021) & (US$ Million)
Table 85. Promega Corporation Recent Development
Table 86. Beijing TransGen Biotech Company Details
Table 87. Beijing TransGen Biotech Business Overview
Table 88. Beijing TransGen Biotech Expression Competent Cells Product
Table 89. Beijing TransGen Biotech Revenue in Expression Competent Cells Business (2016-2021) & (US$ Million)
Table 90. Beijing TransGen Biotech Recent Development
Table 91. GeneScript Corporation Company Details
Table 92. GeneScript Corporation Business Overview
Table 93. GeneScript Corporation Expression Competent Cells Product
Table 94. GeneScript Corporation Revenue in Expression Competent Cells Business (2016-2021) & (US$ Million)
Table 95. GeneScript Corporation Recent Development
Table 96. Yeastern Biotech Company Details
Table 97. Yeastern Biotech Business Overview
Table 98. Yeastern Biotech Revenue in Expression Competent Cells Business (2016-2021) & (US$ Million)
Table 99. Yeastern Biotech Recent Development
Table 100. New England Biolabs Company Details
Table 101. New England Biolabs Business Overview
Table 102. New England Biolabs Expression Competent Cells Product
Table 103. New England Biolabs Revenue in Expression Competent Cells Business (2016-2021) & (US$ Million)
Table 104. New England Biolabs Recent Development
Table 105. QIAGEN N.V. Company Details
Table 106. QIAGEN N.V. Business Overview
Table 107. QIAGEN N.V. Expression Competent Cells Product
Table 108. QIAGEN N.V. Revenue in Expression Competent Cells Business (2016-2021) & (US$ Million)
Table 109. QIAGEN N.V. Recent Development
Table 110. OriGene Technologies Company Details
Table 111. OriGene Technologies Business Overview
Table 112. OriGene Technologies Expression Competent Cells Product
Table 113. OriGene Technologies Revenue in Expression Competent Cells Business (2016-2021) & (US$ Million)
Table 114. OriGene Technologies Recent Development
Table 115. Lucigen Company Details
Table 116. Lucigen Business Overview
Table 117. Lucigen Expression Competent Cells Product
Table 118. Lucigen Revenue in Expression Competent Cells Business (2016-2021) & (US$ Million)
Table 119. Lucigen Recent Development
Table 120. Zymo Research Company Details
Table 121. Zymo Research Business Overview
Table 122. Zymo Research Expression Competent Cells Product
Table 123. Zymo Research Revenue in Expression Competent Cells Business (2016-2021) & (US$ Million)
Table 124. Zymo Research Recent Development
Table 125. Bio-Rad Laboratories Company Details
Table 126. Bio-Rad Laboratories Business Overview
Table 127. Bio-Rad Laboratories Expression Competent Cells Product
Table 128. Bio-Rad Laboratories Revenue in Expression Competent Cells Business (2016-2021) & (US$ Million)
Table 129. Bio-Rad Laboratories Recent Development
Table 130. Bioline Company Details
Table 131. Bioline Business Overview
Table 132. Bioline Expression Competent Cells Product
Table 133. Bioline Revenue in Expression Competent Cells Business (2016-2021) & (US$ Million)
Table 134. Bioline Recent Development
Table 135. Delphi Genetics Company Details
Table 136. Delphi Genetics Business Overview
Table 137. Delphi Genetics Expression Competent Cells Product
Table 138. Delphi Genetics Revenue in Expression Competent Cells Business (2016-2021) & (US$ Million)
Table 139. Delphi Genetics Recent Development
Table 140. IBA GmBH Company Details
Table 141. IBA GmBH Business Overview
Table 142. IBA GmBH Expression Competent Cells Product
Table 143. IBA GmBH Revenue in Expression Competent Cells Business (2016-2021) & (US$ Million)
Table 144. IBA GmBH Recent Development
Table 145. Cell Applications Company Details
Table 146. Cell Applications Business Overview
Table 147. Cell Applications Expression Competent Cells Product
Table 148. Cell Applications Revenue in Expression Competent Cells Business (2016-2021) & (US$ Million)
Table 149. Cell Applications Recent Development
Table 150. BioDynamics Laboratory Company Details
Table 151. BioDynamics Laboratory Business Overview
Table 152. BioDynamics Laboratory Expression Competent Cells Product
Table 153. BioDynamics Laboratory Revenue in Expression Competent Cells Business (2016-2021) & (US$ Million)
Table 154. BioDynamics Laboratory Recent Development
Table 155. Scarab Genomics Company Details
Table 156. Scarab Genomics Business Overview
Table 157. Scarab Genomics Expression Competent Cells Product
Table 158. Scarab Genomics Revenue in Expression Competent Cells Business (2016-2021) & (US$ Million)
Table 159. Scarab Genomics Recent Development
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Expression Competent Cells Market Share by Type: 2020 VS 2027
Figure 2. Chemically Competent Cells Features
Figure 3. Electrocompetent Cells Features
Figure 4. Global Expression Competent Cells Market Share by Application: 2020 VS 2027
Figure 5. Protein Expression Case Studies
Figure 6. Other Case Studies
Figure 7. Expression Competent Cells Report Years Considered
Figure 8. Global Expression Competent Cells Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Expression Competent Cells Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Expression Competent Cells Market Share by Regions: 2020 VS 2027
Figure 11. Global Expression Competent Cells Market Share by Regions (2022-2027)
Figure 12. Global Expression Competent Cells Market Share by Players in 2020
Figure 13. Global Top Expression Competent Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Expression Competent Cells as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Expression Competent Cells Revenue in 2020
Figure 15. Global Expression Competent Cells Revenue Market Share by Type (2016-2021)
Figure 16. Global Expression Competent Cells Revenue Market Share by Type (2022-2027)
Figure 17. North America Expression Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Expression Competent Cells Market Share by Type (2016-2027)
Figure 19. North America Expression Competent Cells Market Share by Application (2016-2027)
Figure 20. North America Expression Competent Cells Market Share by Country (2016-2027)
Figure 21. United States Expression Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Expression Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Expression Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Expression Competent Cells Market Share by Type (2016-2027)
Figure 25. Europe Expression Competent Cells Market Share by Application (2016-2027)
Figure 26. Europe Expression Competent Cells Market Share by Country (2016-2027)
Figure 27. Germany Expression Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Expression Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Expression Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Expression Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Expression Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Expression Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Expression Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Expression Competent Cells Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Expression Competent Cells Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Expression Competent Cells Market Share by Region (2016-2027)
Figure 37. China Expression Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Expression Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Expression Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Expression Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Expression Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Expression Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Expression Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Expression Competent Cells Market Share by Type (2016-2027)
Figure 45. Latin America Expression Competent Cells Market Share by Application (2016-2027)
Figure 46. Latin America Expression Competent Cells Market Share by Country (2016-2027)
Figure 47. Mexico Expression Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Expression Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Expression Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Expression Competent Cells Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Expression Competent Cells Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Expression Competent Cells Market Share by Country (2016-2027)
Figure 53. Turkey Expression Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Expression Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Expression Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Merck KGaA Revenue Growth Rate in Expression Competent Cells Business (2016-2021)
Figure 57. Thermo Fisher Scientific Revenue Growth Rate in Expression Competent Cells Business (2016-2021)
Figure 58. Agilent Technologies Revenue Growth Rate in Expression Competent Cells Business (2016-2021)
Figure 59. Takara Bio Revenue Growth Rate in Expression Competent Cells Business (2016-2021)
Figure 60. Promega Corporation Revenue Growth Rate in Expression Competent Cells Business (2016-2021)
Figure 61. Beijing TransGen Biotech Revenue Growth Rate in Expression Competent Cells Business (2016-2021)
Figure 62. GeneScript Corporation Revenue Growth Rate in Expression Competent Cells Business (2016-2021)
Figure 63. Yeastern Biotech Revenue Growth Rate in Expression Competent Cells Business (2016-2021)
Figure 64. New England Biolabs Revenue Growth Rate in Expression Competent Cells Business (2016-2021)
Figure 65. QIAGEN N.V. Revenue Growth Rate in Expression Competent Cells Business (2016-2021)
Figure 66. OriGene Technologies Revenue Growth Rate in Expression Competent Cells Business (2016-2021)
Figure 67. Lucigen Revenue Growth Rate in Expression Competent Cells Business (2016-2021)
Figure 68. Zymo Research Revenue Growth Rate in Expression Competent Cells Business (2016-2021)
Figure 69. Bio-Rad Laboratories Revenue Growth Rate in Expression Competent Cells Business (2016-2021)
Figure 70. Bioline Revenue Growth Rate in Expression Competent Cells Business (2016-2021)
Figure 71. Delphi Genetics Revenue Growth Rate in Expression Competent Cells Business (2016-2021)
Figure 72. IBA GmBH Revenue Growth Rate in Expression Competent Cells Business (2016-2021)
Figure 73. Cell Applications Revenue Growth Rate in Expression Competent Cells Business (2016-2021)
Figure 74. BioDynamics Laboratory Revenue Growth Rate in Expression Competent Cells Business (2016-2021)
Figure 75. Scarab Genomics Revenue Growth Rate in Expression Competent Cells Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $2900
USD $3900
USD $4900
COVID-19
Offer

WHY US?

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.